Rh Deficiency Syndrome

Mendelian MONDO:0019107 Pathograph 12 Show in embeddings browser

Rh deficiency syndrome is a rare inherited red cell disorder in which the Rh membrane complex is absent or severely reduced, producing a chronic haemolytic anaemia. The Rh antigens familiar from transfusion practice are the visible surface of a multi-subunit assembly that also includes RhAG, CD47, LW, and glycophorin B, and that assembly is structural as well as antigenic: it links to the membrane skeleton and contributes to the mechanical integrity of the cell. Losing it does not merely erase a blood group. The red cell becomes a stomatocyte, loses deformability, and is cleared prematurely from the circulation. Two genetic routes converge on the same missing complex. In the regulator type, biallelic loss of function in RHAG removes the glycoprotein required to assemble and traffic the complex, so Rh antigens disappear even though the RH genes themselves are intact. In the rarer amorph type, silent RHD and RHCE haplotypes remove the Rh polypeptides directly. The first is a failure of assembly, the second a failure of production, and the erythrocyte cannot tell the difference. Two confusions are worth heading off, because both are common and both are wrong. This is not RhD-negative blood type, in which one antigen is absent and the complex is otherwise intact and the red cell is entirely normal. And it is not the RHAG gain-of-function form of overhydrated hereditary stomatocytosis, which is dominant, involves the same gene in the opposite direction, and shares membrane-hydration biology without being the same disease. The practical consequence that dominates management is transfusion. A person whose red cells carry no Rh antigens will form antibodies against essentially any ordinary unit, so compatible blood means Rh-null blood, which is among the rarest in the world.

Ask OpenScientist

Ask a research question about Rh Deficiency Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
5
Phenotypes
1
Gaps
12
Pathograph
3
Genes
2
Medical Actions
4
Differentials
1
Models
1
Deep Research
👪

Inheritance

1
Autosomal recessive HP:0000007
Both the regulator and amorph types are autosomal recessive. Consanguinity is reported in affected families, which is unsurprising for a disease this rare.
Autosomal recessive inheritance
?

Discussions and Knowledge Gaps

1
Why does the severity of haemolysis vary so widely between people with equally complete absence of the Rh complex?
KNOWLEDGE GAP OPEN rh_severity_variability
Attached to
pathophysiology#Reduced Erythrocyte Deformability and Stomatocytic Morphology
The clinical literature consistently describes a varying degree of haemolytic anaemia rather than a uniform severity, and the variation is not obviously explained by which genetic route produced the deficit: regulator and amorph types both abolish the complex and both give a range of outcomes. Candidate explanations include residual expression in the Rhmod phenotypes, differences in the rest of the membrane skeleton, splenic function, and unmeasured modifiers, but with a disease reported in single families the question has never been addressed systematically. It matters because prognosis at diagnosis currently rests on observation rather than on anything measurable.
Proposed experiments
Membrane deformability against haemolytic severity across reported cases
rh_ektacytometry_severity_correlation
Assemble the small number of living reported patients through rare-donor registries and measure osmotic gradient ektacytometry alongside haemolytic indices, testing whether deformability rather than genotype predicts severity. Registry linkage is the only realistic route to a cohort in a disease this rare.
⚙

Pathophysiology

5
RHAG Loss of Function (Regulator Type)
The commoner route. Biallelic loss-of-function variants in RHAG remove the glycoprotein required to assemble and traffic the Rh complex, so the Rh antigens disappear even though the RH genes themselves are intact and their transcripts are made. This is a failure of assembly, and it is the route the RHAG-knockdown experimental model reproduces.
ammonium channel activity GO:0008519 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves ammonium channel activity (GO:0008519), qualified as loss of function. GO:0008519 is a molecular function from the Gene Ontology. ⇓ LOSS OF FUNCTION
Downstream
Absent or Severely Reduced Rh Membrane Complex Without RhAG the complex cannot be assembled or delivered to the membrane.
Show evidence (3 references)
PMID:8563755 SUPPORT Human Clinical
"Most frequently, Rhnull phenotypes are caused by homozygosity of an autosomal suppressor gene unlinked to the RH locus (Rhnull regulator or Rhmod types)."
Establishes the regulator type as the commoner route and that the responsible gene is unlinked to the RH locus, which is why Rh antigens can vanish while the RH genes are intact. It does not name the gene; the next item does.
PMID:8563755 SUPPORT Human Clinical
"In all patients, we identified alteration of Rh50--frameshift, nucleotide mutations, or failure of amplification--which correlated with Rhnull phenotype."
Names the lesion this node is named for. Rh50 is the RHAG gene product, and the alterations reported are the loss-of-function classes the node asserts.
PMID:9716608 SUPPORT Human Clinical
"Rhnull disease includes the amorph and regulator types that are thought to result from homozygous mutations at the RH30 and RH50 loci, respectively."
Assigns the two routes to their two loci in one sentence, which is the claim the split into two initiating nodes encodes.
Silent RH Haplotype (Amorph Type)
The rarer route, and a different kind of failure. A silent RHCE inherited in cis with a deleted RHD means the Rh polypeptides are simply never produced. Nothing is mis-assembled because there is nothing to assemble. Reported families are consanguineous, as expected for a phenotype this rare.
Downstream
Absent or Severely Reduced Rh Membrane Complex No Rh polypeptides are produced, so no complex forms.
Show evidence (2 references)
PMID:16271106 SUPPORT Human Clinical
"The deficiency of Rh proteins on red blood cells (RBCs) from individuals of the Rh(null) amorph type are the result of homozygosity for a silent RHCE in cis with a deleted RHD."
States the haplotype architecture of the amorph type precisely, which is what distinguishes it from the regulator route.
PMID:1503086 SUPPORT Human Clinical
"Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
Documents the amorph type arising from a homozygous silent Rh haplotype in a consanguineous family.
Absent or Severely Reduced Rh Membrane Complex
The convergence point. The Rh complex is not a single antigen but a multi-subunit assembly of Rh polypeptides with RhAG, CD47, LW, and glycophorin B, and in this disease the whole assembly is missing or greatly reduced. That the associated proteins disappear together with the Rh polypeptides is what makes this a membrane structural defect rather than a serological curiosity, and it has been shown experimentally that removing RhAG alone is sufficient to drag the associated proteins off the surface with it.
erythrocyte CL:0000232 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves erythrocyte (CL:0000232). CL:0000232 is a cell type from the Cell Ontology.
ammonium transmembrane transport by the Rh complex GO:0072488 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased ammonium transmembrane transport by the Rh complex, annotated with ammonium transmembrane transport (GO:0072488). GO:0072488 is a biological process from the Gene Ontology. ↓ DECREASED
Experimental models
RhAG-knockdown ex vivo erythroid model PRIMARY CELL CULTURE Reproduces the loss of Rh antigen expression, the membrane deformability defect, and the gas transport abnormality of native Rh-null cells, and shows that removing RhAG alone accounts for loss of the associated surface proteins.
Downstream
Reduced Erythrocyte Deformability and Stomatocytic Morphology Loss of the complex compromises the mechanical properties of the membrane.
Show evidence (3 references)
PMID:23417980 SUPPORT In Vitro
"The cultured red cells generated recapitulate the major alterations of native Rh(null) cells regarding antigen expression, membrane deformability, and gas transport function, providing the proof of principle for their use as model of Rh(null) syndrome and to investigate Rh complex biogenesis in..."
PARTIAL, and the gap is worth naming rather than glossing. The source reports loss of GAS transport function, while the annotation on this node is ammonium transmembrane transport. RhAG carries both, so the observation is consistent with the annotation without being a measurement of it. Graded accordingly rather than asserted at full strength.
PMID:8563755 SUPPORT Human Clinical
"The Rh antigen is a multi-subunit complex composed of Rh polypeptides and associated glycoproteins (Rh50, CD47, LW and glycophorin B); these interact in the red cell membrane and are lacking or severely reduced in Rhnull cells."
Enumerates the components of the complex and states that they are lost together, which is the claim this node makes.
PMID:23417980 SUPPORT In Vitro
"we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh(null) RBCs"
Causal demonstration rather than inference: knocking down RhAG alone reproduces the loss of the associated surface proteins, establishing the dependency implied by the regulator-type genetics.
Reduced Erythrocyte Deformability and Stomatocytic Morphology
The red cell becomes a stomatocyte, with the characteristic slit-like central pallor, and loses the deformability it needs to squeeze repeatedly through capillaries and splenic sinusoids. This is the mechanical consequence of losing a complex that is tethered to the membrane skeleton, and it is reproducible in an engineered model as well as observable on a patient's blood film.
erythrocyte CL:0000232 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves erythrocyte (CL:0000232). CL:0000232 is a cell type from the Cell Ontology.
Downstream
Stomatocytosis The morphological change is what is seen on the film. Recorded as its own edge because the shape abnormality and the loss of deformability are observed differently, one by microscopy and one by rheology, even though they are two faces of the same membrane defect.
Premature Erythrocyte Destruction Rigid, abnormally shaped cells are removed from the circulation early.
Show evidence (2 references)
PMID:10467273 SUPPORT Human Clinical
"Rh(null) is a rare autosomal recessive disorder characterized by an absence of Rh antigens and a varying degree of hemolytic anemia and spherostomatocytosis."
Links the absent antigens to the stomatocytic morphology and the haemolysis in one sentence, and records that severity varies.
PMID:23417980 SUPPORT In Vitro
"Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh(null) syndrome."
Describes the engineered model in which the membrane consequences, including deformability, were reproduced from the molecular lesion alone.
Premature Erythrocyte Destruction
Shortened red cell survival, predominantly extravascular, with the spleen removing cells that can no longer deform enough to pass through it. This is the node at which the membrane defect becomes an anaemia.
Downstream
Hemolytic anemia Destruction outpacing production produces the anaemia.
Reticulocytosis Compensatory erythropoiesis raises the reticulocyte count.
Jaundice Reached through unconjugated hyperbilirubinaemia from haem breakdown.
Splenomegaly The organ doing the clearing enlarges under chronic workload.
Show evidence (1 reference)
PMID:8563755 SUPPORT Human Clinical
"As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
States the consequence of the membrane defect and names the syndrome for it, which is exactly the transition this node carries.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Rh Deficiency Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Blood 2
Hemolytic anemia HP:0001878 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hemolytic anemia (HP:0001878). HP:0001878 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8563755 SUPPORT Human Clinical
"As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
Names chronic haemolytic anaemia as the defining clinical consequence.
Reticulocytosis HP:0001923 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reticulocytosis (HP:0001923). HP:0001923 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8563755 SUPPORT Human Clinical
"As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
PARTIAL: the cited sentence establishes chronic haemolysis, from which reticulocytosis follows as the standard compensatory response, but this source does not report reticulocyte counts in these patients directly.
Cardiovascular 1
Splenomegaly HP:0001744 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Splenomegaly (HP:0001744). HP:0001744 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8563755 SUPPORT Human Clinical
"As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
PARTIAL: establishes the chronic extravascular haemolysis that produces splenomegaly, without this source documenting spleen size. Recorded at that strength deliberately.
Digestive 1
Jaundice HP:0000952 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Jaundice (HP:0000952). HP:0000952 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:1503086 SUPPORT Human Clinical
"Another example of rare red cells that failed to react with all anti-Rh and anti-LW antibodies was discovered in a Spanish woman suffering from a severe hemolytic anemia typical of the Rhnull syndrome."
PARTIAL: documents severe haemolytic anaemia in a patient with the disease, which is the process that produces jaundice, but does not report the sign itself. Curated at that strength rather than asserted.
Other 1
Stomatocytosis HP:0004446 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Stomatocytosis (HP:0004446). HP:0004446 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10467273 SUPPORT Human Clinical
"Rh(null) is a rare autosomal recessive disorder characterized by an absence of Rh antigens and a varying degree of hemolytic anemia and spherostomatocytosis."
Records the stomatocytic morphology alongside the haemolysis, in the authors' own compound term.
🧬

Genetic Associations

3
RHAG
Gene: RHAG hgnc:10006 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is RHAG (hgnc:10006). hgnc:10006 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal recessive
Show evidence (1 reference)
PMID:10467273 SUPPORT Human Clinical
"We report studies of two Japanese Rh(null) cases and describe three new missense mutations of RHAG, the locus that encodes Rh50 glycoprotein and modulates Rh antigen expression."
Identifies RHAG as the locus encoding the glycoprotein that modulates Rh antigen expression, and reports disease-causing missense variants in it.
RHD
Gene: RHD hgnc:10009 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is RHD (hgnc:10009). hgnc:10009 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal recessive
Show evidence (1 reference)
PMID:1503086 SUPPORT Human Clinical
"Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
Documents the amorph type arising from a homozygous silent Rh haplotype in a consanguineous family, which is the route this record describes.
RHCE
Gene: RHCE hgnc:10008 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is RHCE (hgnc:10008). hgnc:10008 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal recessive
Show evidence (1 reference)
PMID:16271106 SUPPORT Human Clinical
"The deficiency of Rh proteins on red blood cells (RBCs) from individuals of the Rh(null) amorph type are the result of homozygosity for a silent RHCE in cis with a deleted RHD."
States the genetic architecture of the amorph type precisely: a silent RHCE inherited in cis with a deleted RHD, which is why this record and the RHD record describe two halves of one haplotype rather than two independent causes.
💊

Medical Actions

2
Transfusion Support with Rare-Donor Blood
Action: Blood TransfusionNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Blood Transfusion (NCIT:C15192). NCIT:C15192 is a clinical intervention from the NCI Thesaurus. NCIT:C15192
The defining management problem, and it is logistical as much as medical. A person whose red cells express no Rh antigens will recognise essentially any ordinary donor unit as foreign, so compatible blood means Rh-null blood, which is among the rarest phenotypes recorded. Practical consequences follow: advance planning, rare-donor registry linkage, and where feasible autologous donation and storage during periods of stability, because a unit cannot be found at short notice.
Mechanism Target:
MODULATES Hemolytic anemia — Replaces destroyed red cells without altering the underlying membrane defect. Supportive rather than corrective, and constrained by compatibility.
Show evidence (1 reference)
PMID:8563755 SUPPORT Human Clinical
"As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
Establishes the chronic anaemia that transfusion supports.
Genetic Counselling and Family Studies
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal recessive recurrence risk, carrier testing within affected pedigrees, and something unusual to this disease: identification of relatives who may share the rare phenotype and could serve as compatible donors. The family study is simultaneously genetic counselling and transfusion planning.
Show evidence (1 reference)
PMID:1503086 SUPPORT Human Clinical
"Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
Demonstrates the family study establishing both the inheritance and the distribution of the phenotype within a pedigree.
🔬

Diagnosis

2
Rh serology (Rh-null and Rhmod phenotyping)
The diagnostic hallmark, and the finding every differential in this entry ultimately turns on. Red cells fail to react with anti-Rh and anti-LW antisera, establishing absence of the whole complex rather than of a single antigen. Rhmod denotes markedly reduced rather than wholly absent expression. The result carries a consequence beyond diagnosis: it identifies a person for whom ordinary donor blood is incompatible, so the serology that names the disease also creates the transfusion problem.
Rh phenotyping NCIT:C210738 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:16271106 SUPPORT Human Clinical
"Rh(null) RBCs were nonreactive with anti-Rh and anti-LW."
The serological finding that defines the phenotype, showing loss of both Rh and LW reactivity rather than a single missing antigen.
Molecular testing of RHAG, RHD and RHCE
Sequencing distinguishes the regulator type, where RHAG is disrupted and the RH genes are intact, from the amorph type, where a silent RHCE sits in cis with a deleted RHD. The distinction does not change transfusion management but does change genetic counselling and determines which relatives to test.
Show evidence (1 reference)
PMID:10467273 SUPPORT Human Clinical
"We report studies of two Japanese Rh(null) cases and describe three new missense mutations of RHAG, the locus that encodes Rh50 glycoprotein and modulates Rh antigen expression."
Demonstrates molecular characterisation of the regulator type through RHAG sequencing.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No reliable population prevalence, incidence, sex ratio, or carrier frequency is established. The disease is described through individual patients and small, often consanguineous families, and the source deep-research report is explicit that quantitative rates should be marked unavailable rather than inferred. Recorded as CASES_IN_LITERATURE for that reason. The rarity is not merely epidemiological trivia here: it is the reason compatible blood is almost unobtainable and the reason no cohort exists in which to study severity.
Show evidence (1 reference)
PMID:1503086 SUPPORT Human Clinical
"Another example of rare red cells that failed to react with all anti-Rh and anti-LW antibodies was discovered in a Spanish woman suffering from a severe hemolytic anemia typical of the Rhnull syndrome."
Illustrates the form the literature takes, a single patient reported as another example of a rare phenotype, which is why no rate is curated.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Rh Deficiency Syndrome:

RhD-negative blood type
Overlapping Features Not a differential in the usual sense but the most common confusion, and worth stating explicitly. RhD-negative individuals lack the D antigen while retaining the rest of the Rh complex and an entirely normal red cell membrane. They have no haemolysis and no disease. The similarity is nominal.
Overhydrated hereditary stomatocytosis (RHAG gain of function)
Overlapping Features The most instructive differential, because it involves the same gene in the opposite direction. Gain-of-function RHAG variants produce a dominantly inherited overhydrated stomatocytosis with cation leak, whereas this disease arises from recessive loss of function. Reviews often discuss the two together under red-cell membrane transport disorders, and phenotype frequencies from that spectrum should not be carried across.
Hereditary spherocytosis
Overlapping Features The commonest inherited membrane haemolytic anaemia, and the main alternative when a patient presents with chronic haemolysis and abnormal red cell morphology. Distinguished by spherocytes rather than stomatocytes, by the vertical-interaction proteins involved, and definitively by Rh serology, which is normal.
Dehydrated hereditary stomatocytosis
Overlapping Features Xerocytosis, the mirror-image cation-leak disorder, in which red cells lose water rather than gain it. Shares the stomatocytic label and the membrane transport theme; distinguished by ektacytometry and by normal Rh antigen expression.
🧫

Experimental Models

1
RhAG-knockdown ex vivo erythroid model PRIMARY_CELL_CULTURE
Lentiviral knockdown of RhAG in cells undergoing ex vivo erythroid differentiation, generating red cells that reproduce the native Rh-null phenotype. It is the closest thing to an experimental system for a disease too rare for one, and it converts an inference drawn from patient genetics into a demonstration.
Pathograph links
Absent or Severely Reduced Rh Membrane Complex recapitulates fidelity: high Reproduces the loss of Rh antigen expression, the membrane deformability defect, and the gas transport abnormality of native Rh-null cells, and shows that removing RhAG alone accounts for loss of the associated surface proteins.
Limitations: The model addresses the regulator type only, since it works by removing RhAG; the amorph type, now curated as its own upstream node, arises from silent RH haplotypes and is not reproduced. Cells are generated by ex vivo differentiation rather than surviving in a circulation, so red cell lifespan itself cannot be measured.
Show evidence (1 reference)
PMID:23417980 SUPPORT In Vitro
"we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh(null) RBCs"
The sufficiency claim this model establishes, which is what makes it informative for the complex-assembly node rather than merely consistent with it.
Show evidence (1 reference)
PMID:23417980 SUPPORT In Vitro
"Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh(null) syndrome."
Describes the construction of the model and its intended relationship to the disease.
{ }

Source YAML

click to show 
name: Rh Deficiency Syndrome
creation_date: "2026-08-16T00:00:00Z"
description: >-
  Rh deficiency syndrome is a rare inherited red cell disorder in which the Rh
  membrane complex is absent or severely reduced, producing a chronic haemolytic
  anaemia. The Rh antigens familiar from transfusion practice are the visible
  surface of a multi-subunit assembly that also includes RhAG, CD47, LW, and
  glycophorin B, and that assembly is structural as well as antigenic: it links
  to the membrane skeleton and contributes to the mechanical integrity of the
  cell. Losing it does not merely erase a blood group. The red cell becomes a
  stomatocyte, loses deformability, and is cleared prematurely from the
  circulation.

  Two genetic routes converge on the same missing complex. In the regulator
  type, biallelic loss of function in RHAG removes the glycoprotein required to
  assemble and traffic the complex, so Rh antigens disappear even though the RH
  genes themselves are intact. In the rarer amorph type, silent RHD and RHCE
  haplotypes remove the Rh polypeptides directly. The first is a failure of
  assembly, the second a failure of production, and the erythrocyte cannot tell
  the difference.

  Two confusions are worth heading off, because both are common and both are
  wrong. This is not RhD-negative blood type, in which one antigen is absent and
  the complex is otherwise intact and the red cell is entirely normal. And it is
  not the RHAG gain-of-function form of overhydrated hereditary stomatocytosis,
  which is dominant, involves the same gene in the opposite direction, and shares
  membrane-hydration biology without being the same disease.

  The practical consequence that dominates management is transfusion. A person
  whose red cells carry no Rh antigens will form antibodies against essentially
  any ordinary unit, so compatible blood means Rh-null blood, which is among the
  rarest in the world.
category: Mendelian
disease_term:
  preferred_term: Rh Deficiency Syndrome
  term:
    id: MONDO:0019107
    label: Rh deficiency syndrome
synonyms:
- Rh-null syndrome
- Rhnull disease
- Rh-null phenotype
notes: >-
  Scope and boundaries. Two distinctions are curated deliberately because the
  literature blurs them. First, this disease is not RhD-negative blood type:
  there the D antigen is absent, the rest of the Rh complex is intact, and there
  is no haemolysis at all. Second, it is not RHAG gain-of-function overhydrated
  hereditary stomatocytosis, which is autosomal dominant, arises from the same
  gene acting in the opposite direction, and shares red-cell hydration biology
  without sharing the mechanism. Reviews frequently discuss the two together, and
  phenotype frequencies quoted for the stomatocytosis spectrum should not be
  read across to this entry.

  Frequencies deliberately absent. The source deep-research report states plainly
  that population prevalence, incidence, sex ratio, and carrier frequency are not
  robustly established, and that explicit estimates should be marked unavailable
  rather than inferred. No frequency bands are assigned to phenotypes here for
  the same reason: the literature is single cases and small families, and a band
  derived from a handful of reported patients would manufacture precision the
  data do not have.

  Ontology placement. MONDO classifies this disease under hereditary
  stomatocytosis, and several of its synonyms are regulator-type specific. That
  placement is consistent with the membrane phenotype curated here and should not
  be read as contradicting the exclusion of RHAG gain-of-function overhydrated
  stomatocytosis below: the two share a stomatocytic morphology and a position in
  the membrane-disorder family while differing in gene direction, inheritance and
  mechanism.

  Provider note and a caught error. Built from an Edison Falcon deep-research
  report. Falcon cites by DOI and internal corpus keys rather than PMIDs, so
  evidence here is sourced from the PubMed records it named through Open Targets
  and verified against those. The report gave RHAG the identifier HGNC:9881,
  which does not resolve; the correct identifier is hgnc:10006, verified against
  the ontology and used here. Its RHD and RHCE identifiers were correct. The
  error is recorded because it affected the single most important gene in the
  disease and would not have been caught by snippet validation.
pathophysiology:
- name: RHAG Loss of Function (Regulator Type)
  biological_scale: MOLECULAR
  description: >-
    The commoner route. Biallelic loss-of-function variants in RHAG remove the
    glycoprotein required to assemble and traffic the Rh complex, so the Rh
    antigens disappear even though the RH genes themselves are intact and their
    transcripts are made. This is a failure of assembly, and it is the route the
    RHAG-knockdown experimental model reproduces.
  molecular_functions:
  - preferred_term: ammonium channel activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0008519
      label: ammonium channel activity
  evidence:
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most frequently, Rhnull phenotypes are caused by homozygosity of an autosomal suppressor gene unlinked to the RH locus (Rhnull regulator or Rhmod types)."
    explanation: >-
      Establishes the regulator type as the commoner route and that the
      responsible gene is unlinked to the RH locus, which is why Rh antigens can
      vanish while the RH genes are intact. It does not name the gene; the next
      item does.
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In all patients, we identified alteration of Rh50--frameshift, nucleotide mutations, or failure of amplification--which correlated with Rhnull phenotype."
    explanation: >-
      Names the lesion this node is named for. Rh50 is the RHAG gene product, and
      the alterations reported are the loss-of-function classes the node asserts.
  - reference: PMID:9716608
    reference_title: "Rh50 glycoprotein gene and rhnull disease: a silent splice donor is trans to a Gly279-->Glu missense mutation in the conserved transmembrane segment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rhnull disease includes the amorph and regulator types that are thought to result from homozygous mutations at the RH30 and RH50 loci, respectively."
    explanation: >-
      Assigns the two routes to their two loci in one sentence, which is the
      claim the split into two initiating nodes encodes.
  downstream:
  - target: Absent or Severely Reduced Rh Membrane Complex
    causal_link_type: DIRECT
    description: >-
      Without RhAG the complex cannot be assembled or delivered to the membrane.
- name: Silent RH Haplotype (Amorph Type)
  biological_scale: MOLECULAR
  description: >-
    The rarer route, and a different kind of failure. A silent RHCE inherited in
    cis with a deleted RHD means the Rh polypeptides are simply never produced.
    Nothing is mis-assembled because there is nothing to assemble. Reported
    families are consanguineous, as expected for a phenotype this rare.
  evidence:
  - reference: PMID:16271106
    reference_title: "Rhnull syndrome: identification of a novel mutation in RHce."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The deficiency of Rh proteins on red blood cells (RBCs) from individuals of the Rh(null) amorph type are the result of homozygosity for a silent RHCE in cis with a deleted RHD."
    explanation: >-
      States the haplotype architecture of the amorph type precisely, which is
      what distinguishes it from the regulator route.
  - reference: PMID:1503086
    reference_title: "Spanish Rhnull family caused by a silent Rh gene: hematological, serological, and biochemical studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
    explanation: >-
      Documents the amorph type arising from a homozygous silent Rh haplotype in a
      consanguineous family.
  downstream:
  - target: Absent or Severely Reduced Rh Membrane Complex
    causal_link_type: DIRECT
    description: >-
      No Rh polypeptides are produced, so no complex forms.
- name: Absent or Severely Reduced Rh Membrane Complex
  biological_scale: MOLECULAR
  description: >-
    The convergence point. The Rh complex is not a single antigen but a
    multi-subunit assembly of Rh polypeptides with RhAG, CD47, LW, and
    glycophorin B, and in this disease the whole assembly is missing or greatly
    reduced. That the associated proteins disappear together with the Rh
    polypeptides is what makes this a membrane structural defect rather than a
    serological curiosity, and it has been shown experimentally that removing
    RhAG alone is sufficient to drag the associated proteins off the surface with
    it.
  cell_types:
  - preferred_term: erythrocyte
    term:
      id: CL:0000232
      label: erythrocyte
  biological_processes:
  - preferred_term: ammonium transmembrane transport by the Rh complex
    modifier: DECREASED
    term:
      id: GO:0072488
      label: ammonium transmembrane transport
  evidence:
  - reference: PMID:23417980
    reference_title: "In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The cultured red cells generated recapitulate the major alterations of native Rh(null) cells regarding antigen expression, membrane deformability, and gas transport function, providing the proof of principle for their use as model of Rh(null) syndrome and to investigate Rh complex biogenesis in human primary erythroid cells."
    explanation: >-
      PARTIAL, and the gap is worth naming rather than glossing. The source
      reports loss of GAS transport function, while the annotation on this node is
      ammonium transmembrane transport. RhAG carries both, so the observation is
      consistent with the annotation without being a measurement of it. Graded
      accordingly rather than asserted at full strength.
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The Rh antigen is a multi-subunit complex composed of Rh polypeptides and associated glycoproteins (Rh50, CD47, LW and glycophorin B); these interact in the red cell membrane and are lacking or severely reduced in Rhnull cells."
    explanation: >-
      Enumerates the components of the complex and states that they are lost
      together, which is the claim this node makes.
  - reference: PMID:23417980
    reference_title: "In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh(null) RBCs"
    explanation: >-
      Causal demonstration rather than inference: knocking down RhAG alone
      reproduces the loss of the associated surface proteins, establishing the
      dependency implied by the regulator-type genetics.
  downstream:
  - target: Reduced Erythrocyte Deformability and Stomatocytic Morphology
    causal_link_type: DIRECT
    description: >-
      Loss of the complex compromises the mechanical properties of the membrane.
- name: Reduced Erythrocyte Deformability and Stomatocytic Morphology
  biological_scale: CELLULAR
  description: >-
    The red cell becomes a stomatocyte, with the characteristic slit-like central
    pallor, and loses the deformability it needs to squeeze repeatedly through
    capillaries and splenic sinusoids. This is the mechanical consequence of
    losing a complex that is tethered to the membrane skeleton, and it is
    reproducible in an engineered model as well as observable on a patient's
    blood film.
  conforms_to: "hemolytic_anemia_erythrocyte_destruction#Reduced Erythrocyte Integrity"
  cell_types:
  - preferred_term: erythrocyte
    term:
      id: CL:0000232
      label: erythrocyte
  evidence:
  - reference: PMID:10467273
    reference_title: "Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rh(null) is a rare autosomal recessive disorder characterized by an absence of Rh antigens and a varying degree of hemolytic anemia and spherostomatocytosis."
    explanation: >-
      Links the absent antigens to the stomatocytic morphology and the haemolysis
      in one sentence, and records that severity varies.
  - reference: PMID:23417980
    reference_title: "In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh(null) syndrome."
    explanation: >-
      Describes the engineered model in which the membrane consequences,
      including deformability, were reproduced from the molecular lesion alone.
  downstream:
  - target: Stomatocytosis
    causal_link_type: DIRECT
    description: >-
      The morphological change is what is seen on the film. Recorded as its own
      edge because the shape abnormality and the loss of deformability are
      observed differently, one by microscopy and one by rheology, even though
      they are two faces of the same membrane defect.
  - target: Premature Erythrocyte Destruction
    causal_link_type: DIRECT
    description: >-
      Rigid, abnormally shaped cells are removed from the circulation early.
- name: Premature Erythrocyte Destruction
  biological_scale: TISSUE
  description: >-
    Shortened red cell survival, predominantly extravascular, with the spleen
    removing cells that can no longer deform enough to pass through it. This is
    the node at which the membrane defect becomes an anaemia.
  conforms_to: "hemolytic_anemia_erythrocyte_destruction#Premature Erythrocyte Destruction"
  evidence:
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
    explanation: >-
      States the consequence of the membrane defect and names the syndrome for
      it, which is exactly the transition this node carries.
  downstream:
  - target: Hemolytic anemia
    causal_link_type: DIRECT
    description: >-
      Destruction outpacing production produces the anaemia.
  - target: Reticulocytosis
    causal_link_type: DIRECT
    description: >-
      Compensatory erythropoiesis raises the reticulocyte count.
  - target: Jaundice
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Reached through unconjugated hyperbilirubinaemia from haem breakdown.
  - target: Splenomegaly
    causal_link_type: DIRECT
    description: >-
      The organ doing the clearing enlarges under chronic workload.
phenotypes:
- name: Hemolytic anemia
  category: Haematological
  description: >-
    Chronic haemolytic anaemia of variable severity, present from birth. Severity
    ranges widely between reported patients and is not predicted by the genetic
    type.
  phenotype_term:
    preferred_term: Hemolytic anemia
    term:
      id: HP:0001878
      label: Hemolytic anemia
  evidence:
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
    explanation: >-
      Names chronic haemolytic anaemia as the defining clinical consequence.
- name: Stomatocytosis
  category: Haematological
  description: >-
    Stomatocytes on the peripheral blood film, the morphological clue that points
    from an unexplained haemolytic anaemia toward a membrane disorder. Reported
    descriptions include spherostomatocytosis, reflecting a mixture of shapes
    rather than a single uniform morphology.
  phenotype_term:
    preferred_term: Stomatocytosis
    term:
      id: HP:0004446
      label: Stomatocytosis
  evidence:
  - reference: PMID:10467273
    reference_title: "Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rh(null) is a rare autosomal recessive disorder characterized by an absence of Rh antigens and a varying degree of hemolytic anemia and spherostomatocytosis."
    explanation: >-
      Records the stomatocytic morphology alongside the haemolysis, in the
      authors' own compound term.
- name: Reticulocytosis
  category: Haematological
  description: >-
    Raised reticulocyte count from compensatory erythropoiesis, the expected
    marrow response to shortened red cell survival.
  phenotype_term:
    preferred_term: Reticulocytosis
    term:
      id: HP:0001923
      label: Reticulocytosis
  evidence:
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
    explanation: >-
      PARTIAL: the cited sentence establishes chronic haemolysis, from which
      reticulocytosis follows as the standard compensatory response, but this
      source does not report reticulocyte counts in these patients directly.
- name: Jaundice
  category: Clinical
  description: >-
    Jaundice from unconjugated hyperbilirubinaemia, a consequence of ongoing
    haem breakdown rather than of liver disease.
  phenotype_term:
    preferred_term: Jaundice
    term:
      id: HP:0000952
      label: Jaundice
  evidence:
  - reference: PMID:1503086
    reference_title: "Spanish Rhnull family caused by a silent Rh gene: hematological, serological, and biochemical studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Another example of rare red cells that failed to react with all anti-Rh and anti-LW antibodies was discovered in a Spanish woman suffering from a severe hemolytic anemia typical of the Rhnull syndrome."
    explanation: >-
      PARTIAL: documents severe haemolytic anaemia in a patient with the disease,
      which is the process that produces jaundice, but does not report the sign
      itself. Curated at that strength rather than asserted.
- name: Splenomegaly
  category: Clinical
  description: >-
    Enlargement of the spleen under the chronic workload of clearing abnormal red
    cells. Note that splenectomy is approached with caution in the wider
    membrane-transport disorder spectrum, so the finding does not straightforwardly
    imply the operation.
  phenotype_term:
    preferred_term: Splenomegaly
    term:
      id: HP:0001744
      label: Splenomegaly
  evidence:
  - reference: PMID:8563755
    reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
    explanation: >-
      PARTIAL: establishes the chronic extravascular haemolysis that produces
      splenomegaly, without this source documenting spleen size. Recorded at that
      strength deliberately.
genetic:
- name: RHAG
  gene_term:
    preferred_term: RHAG
    term:
      id: hgnc:10006
      label: RHAG
  relationship_type: CAUSATIVE
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
  notes: >-
    Encodes the Rh-associated glycoprotein, required for assembly and surface
    expression of the Rh complex. Biallelic loss of function causes the regulator
    type, the commoner form, in which Rh antigens are absent despite intact RH
    genes. Reported variants include missense changes in transmembrane segments
    and splice-site changes. Note the identifier: hgnc:10006, verified against the
    ontology. The source deep-research report gave HGNC:9881 for this gene, which
    does not resolve.

    Distinguish carefully from RHAG gain-of-function variants, which cause
    autosomal dominant overhydrated hereditary stomatocytosis. Same gene,
    opposite direction of effect, different inheritance, different disease.
  evidence:
  - reference: PMID:10467273
    reference_title: "Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report studies of two Japanese Rh(null) cases and describe three new missense mutations of RHAG, the locus that encodes Rh50 glycoprotein and modulates Rh antigen expression."
    explanation: >-
      Identifies RHAG as the locus encoding the glycoprotein that modulates Rh
      antigen expression, and reports disease-causing missense variants in it.
- name: RHD
  gene_term:
    preferred_term: RHD
    term:
      id: hgnc:10009
      label: RHD
  relationship_type: CAUSATIVE
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
  notes: >-
    Encodes the RhD polypeptide. Silent RHD haplotypes, inherited together with
    silent RHCE, cause the rarer amorph type, in which the Rh polypeptides are
    not produced at all. Being RhD-negative in the ordinary blood-group sense is
    an entirely different matter and does not cause this disease.
  evidence:
  - reference: PMID:1503086
    reference_title: "Spanish Rhnull family caused by a silent Rh gene: hematological, serological, and biochemical studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
    explanation: >-
      Documents the amorph type arising from a homozygous silent Rh haplotype in
      a consanguineous family, which is the route this record describes.
- name: RHCE
  gene_term:
    preferred_term: RHCE
    term:
      id: hgnc:10008
      label: RHCE
  relationship_type: CAUSATIVE
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
  notes: >-
    Encodes the RhCcEe polypeptides. Silent RHCE alleles contribute to the amorph
    type alongside RHD, and a novel RHce variant has been reported as a cause of
    the syndrome.
  evidence:
  - reference: PMID:16271106
    reference_title: "Rhnull syndrome: identification of a novel mutation in RHce."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The deficiency of Rh proteins on red blood cells (RBCs) from individuals of the Rh(null) amorph type are the result of homozygosity for a silent RHCE in cis with a deleted RHD."
    explanation: >-
      States the genetic architecture of the amorph type precisely: a silent RHCE
      inherited in cis with a deleted RHD, which is why this record and the RHD
      record describe two halves of one haplotype rather than two independent
      causes.
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Both the regulator and amorph types are autosomal recessive. Consanguinity is
    reported in affected families, which is unsurprising for a disease this rare.
diagnosis:
- name: Rh serology (Rh-null and Rhmod phenotyping)
  diagnosis_term:
    preferred_term: Rh phenotyping
    term:
      id: NCIT:C210738
      label: Blood Typing Test
  description: >-
    The diagnostic hallmark, and the finding every differential in this entry
    ultimately turns on. Red cells fail to react with anti-Rh and anti-LW
    antisera, establishing absence of the whole complex rather than of a single
    antigen. Rhmod denotes markedly reduced rather than wholly absent expression.
    The result carries a consequence beyond diagnosis: it identifies a person for
    whom ordinary donor blood is incompatible, so the serology that names the
    disease also creates the transfusion problem.
  evidence:
  - reference: PMID:16271106
    reference_title: "Rhnull syndrome: identification of a novel mutation in RHce."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rh(null) RBCs were nonreactive with anti-Rh and anti-LW."
    explanation: >-
      The serological finding that defines the phenotype, showing loss of both Rh
      and LW reactivity rather than a single missing antigen.
- name: Molecular testing of RHAG, RHD and RHCE
  description: >-
    Sequencing distinguishes the regulator type, where RHAG is disrupted and the
    RH genes are intact, from the amorph type, where a silent RHCE sits in cis
    with a deleted RHD. The distinction does not change transfusion management but
    does change genetic counselling and determines which relatives to test.
  evidence:
  - reference: PMID:10467273
    reference_title: "Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report studies of two Japanese Rh(null) cases and describe three new missense mutations of RHAG, the locus that encodes Rh50 glycoprotein and modulates Rh antigen expression."
    explanation: >-
      Demonstrates molecular characterisation of the regulator type through RHAG
      sequencing.
treatments:
- name: Transfusion Support with Rare-Donor Blood
  description: >-
    The defining management problem, and it is logistical as much as medical. A
    person whose red cells express no Rh antigens will recognise essentially any
    ordinary donor unit as foreign, so compatible blood means Rh-null blood,
    which is among the rarest phenotypes recorded. Practical consequences follow:
    advance planning, rare-donor registry linkage, and where feasible autologous
    donation and storage during periods of stability, because a unit cannot be
    found at short notice.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Blood Transfusion
    term:
      id: NCIT:C15192
      label: Blood Transfusion
  target_mechanisms:
  - target: Hemolytic anemia
    treatment_effect: MODULATES
    description: >-
      Replaces destroyed red cells without altering the underlying membrane
      defect. Supportive rather than corrective, and constrained by
      compatibility.
    evidence:
    - reference: PMID:8563755
      reference_title: "Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "As a result, individuals with Rhnull suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome."
      explanation: >-
        Establishes the chronic anaemia that transfusion supports.
- name: Genetic Counselling and Family Studies
  description: >-
    Autosomal recessive recurrence risk, carrier testing within affected
    pedigrees, and something unusual to this disease: identification of relatives
    who may share the rare phenotype and could serve as compatible donors. The
    family study is simultaneously genetic counselling and transfusion planning.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:1503086
    reference_title: "Spanish Rhnull family caused by a silent Rh gene: hematological, serological, and biochemical studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Family study and Rh blood typings demonstrated clearly that the proposita was homozygous for a silent Rh gene complex (Rhnull of the amorph type) that she inherited from her parents who are first cousins."
    explanation: >-
      Demonstrates the family study establishing both the inheritance and the
      distribution of the phenotype within a pedigree.
experimental_models:
- name: RhAG-knockdown ex vivo erythroid model
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: >-
    Lentiviral knockdown of RhAG in cells undergoing ex vivo erythroid
    differentiation, generating red cells that reproduce the native Rh-null
    phenotype. It is the closest thing to an experimental system for a disease
    too rare for one, and it converts an inference drawn from patient genetics
    into a demonstration.
  modeled_mechanisms:
  - target: Absent or Severely Reduced Rh Membrane Complex
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Reproduces the loss of Rh antigen expression, the membrane deformability
      defect, and the gas transport abnormality of native Rh-null cells, and
      shows that removing RhAG alone accounts for loss of the associated surface
      proteins.
    limitations: >-
      The model addresses the regulator type only, since it works by removing
      RhAG; the amorph type, now curated as its own upstream node, arises from
      silent RH haplotypes and is not reproduced. Cells are generated by ex vivo
      differentiation rather than surviving in a circulation, so red cell
      lifespan itself cannot be measured.
    evidence:
    - reference: PMID:23417980
      reference_title: "In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "we were able to reveal for the first time that RhAG extinction alone is sufficient to explain ICAM-4 and CD47 loss observed on native Rh(null) RBCs"
      explanation: >-
        The sufficiency claim this model establishes, which is what makes it
        informative for the complex-assembly node rather than merely consistent
        with it.
  evidence:
  - reference: PMID:23417980
    reference_title: "In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Lentiviral modification combined with ex vivo erythroid differentiation was used to stably inhibit RhAG expression, a critical component of the Rh(rhesus) membrane complex defective in the Rh(null) syndrome."
    explanation: >-
      Describes the construction of the model and its intended relationship to
      the disease.
discussions:
- discussion_id: rh_severity_variability
  prompt: >-
    Why does the severity of haemolysis vary so widely between people with
    equally complete absence of the Rh complex?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Reduced Erythrocyte Deformability and Stomatocytic Morphology
  rationale: >-
    The clinical literature consistently describes a varying degree of haemolytic
    anaemia rather than a uniform severity, and the variation is not obviously
    explained by which genetic route produced the deficit: regulator and amorph
    types both abolish the complex and both give a range of outcomes. Candidate
    explanations include residual expression in the Rhmod phenotypes, differences
    in the rest of the membrane skeleton, splenic function, and unmeasured
    modifiers, but with a disease reported in single families the question has
    never been addressed systematically. It matters because prognosis at
    diagnosis currently rests on observation rather than on anything measurable.
  proposed_experiments:
  - experiment_id: rh_ektacytometry_severity_correlation
    name: Membrane deformability against haemolytic severity across reported cases
    description: >-
      Assemble the small number of living reported patients through rare-donor
      registries and measure osmotic gradient ektacytometry alongside haemolytic
      indices, testing whether deformability rather than genotype predicts
      severity. Registry linkage is the only realistic route to a cohort in a
      disease this rare.
differential_diagnoses:
- name: RhD-negative blood type
  description: >-
    Not a differential in the usual sense but the most common confusion, and
    worth stating explicitly. RhD-negative individuals lack the D antigen while
    retaining the rest of the Rh complex and an entirely normal red cell
    membrane. They have no haemolysis and no disease. The similarity is nominal.
- name: Overhydrated hereditary stomatocytosis (RHAG gain of function)
  description: >-
    The most instructive differential, because it involves the same gene in the
    opposite direction. Gain-of-function RHAG variants produce a dominantly
    inherited overhydrated stomatocytosis with cation leak, whereas this disease
    arises from recessive loss of function. Reviews often discuss the two
    together under red-cell membrane transport disorders, and phenotype
    frequencies from that spectrum should not be carried across.
- name: Hereditary spherocytosis
  description: >-
    The commonest inherited membrane haemolytic anaemia, and the main
    alternative when a patient presents with chronic haemolysis and abnormal red
    cell morphology. Distinguished by spherocytes rather than stomatocytes, by
    the vertical-interaction proteins involved, and definitively by Rh
    serology, which is normal.
- name: Dehydrated hereditary stomatocytosis
  description: >-
    Xerocytosis, the mirror-image cation-leak disorder, in which red cells lose
    water rather than gain it. Shares the stomatocytic label and the membrane
    transport theme; distinguished by ektacytometry and by normal Rh antigen
    expression.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No reliable population prevalence, incidence, sex ratio, or carrier frequency
    is established. The disease is described through individual patients and
    small, often consanguineous families, and the source deep-research report is
    explicit that quantitative rates should be marked unavailable rather than
    inferred. Recorded as CASES_IN_LITERATURE for that reason. The rarity is not
    merely epidemiological trivia here: it is the reason compatible blood is
    almost unobtainable and the reason no cohort exists in which to study
    severity.
  evidence:
  - reference: PMID:1503086
    reference_title: "Spanish Rhnull family caused by a silent Rh gene: hematological, serological, and biochemical studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Another example of rare red cells that failed to react with all anti-Rh and anti-LW antibodies was discovered in a Spanish woman suffering from a severe hemolytic anemia typical of the Rhnull syndrome."
    explanation: >-
      Illustrates the form the literature takes, a single patient reported as
      another example of a rare phenotype, which is why no rate is curated.
📚

References & Deep Research

Deep Research

1
Falcon ▸
Rh Deficiency Syndrome: Disease Characteristics Research Report
Edison Scientific Literature 29 citations 2026-08-16T20:13:58.174752

Rh Deficiency Syndrome: Disease Characteristics Research Report

Executive summary

Rh deficiency syndrome is an exceptionally rare, inherited erythrocyte-membrane disorder defined serologically by absence (Rh-null) or marked reduction (Rhmod) of Rh blood-group antigens and clinically by variable chronic hemolytic anemia, stomatocytosis, reduced red-cell deformability, and shortened erythrocyte survival. The classical disease has two genetic forms: regulator type, usually caused by biallelic loss-of-function variants in RHAG, and amorph type, caused by inheritance of nonfunctional RHD/RHCE backgrounds. Open Targets maps the condition to MONDO:0019107 and ranks RHAG as the strongest associated target, followed by RHCE and RHD. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE)

A critical curation distinction is that classical autosomal-recessive Rh-null deficiency is not identical to autosomal-dominant RHAG gain-of-function overhydrated hereditary stomatocytosis. The disorders share Rh-complex and red-cell hydration biology, and older literature sometimes discusses them together. (andolfo2018hereditarystomatocytosisan pages 9-12, narla2017redcellmembrane pages 4-5)

The following table provides a compact ontology-ready summary; the narrative afterward supplies interpretation and evidence qualifications.

domain curated finding evidence type/strength suggested ontology terms
Disease identity Rh deficiency syndrome is a rare inherited red-cell membrane disorder characterized by absent or markedly reduced Rh antigen expression with membrane instability and chronic hemolysis; disease mapping available as MONDO:0019107. Data are derived from aggregated disease literature and rare individual case reports/series rather than EHR-scale cohorts. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE, iolascon2019advancesinunderstanding pages 1-2) Moderate: disease-level ontology mapping plus review literature; limited by rarity MONDO:0019107; UBERON:0000178 blood; CL:0000232 erythrocyte
Synonyms / serologic terms Common names include Rh deficiency syndrome, Rh-null syndrome, Rhnull phenotype, and Rhmod syndrome (for regulator-type reduced/modified Rh expression due to RHAG defects). (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE) Moderate: established transfusion/genetic nomenclature in foundational literature curated through disease-target evidence MONDO:0019107
Genetic etiology Two classical molecular classes are recognized: regulator type caused by RHAG defects, and amorph type caused by defects in RHD/RHCE leading to absence of Rh antigens. Open Targets disease associations support RHAG, RHCE, and RHD for Rh deficiency syndrome. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE, andolfo2018hereditarystomatocytosisan pages 9-12) Strong for gene-disease association: curated human genetic evidence; strongest for RHAG HGNC:9881 RHAG; HGNC:10009 RHD; HGNC:10008 RHCE
Inheritance The core Rh-null syndrome is typically autosomal recessive in both regulator-type RHAG deficiency and amorph-type combined RH gene defects. Distinguish from overhydrated hereditary stomatocytosis due to RHAG gain-of-function, which is often autosomal dominant and is related but not equivalent disease biology. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE, andolfo2018hereditarystomatocytosisan pages 9-12, narla2017redcellmembrane pages 4-5) Moderate: consistent with foundational case literature and membrane-disorder reviews; some mechanistic overlap with RHAG-related stomatocytosis HP:0000007 Autosomal recessive inheritance; HP:0000006 Autosomal dominant inheritance (differential/related RHAG disorder)
Core pathophysiology RhAG is a membrane glycoprotein in the Rh complex with Rh proteins and associated proteins; the complex interacts with the membrane skeleton directly/indirectly via ankyrin R, CD47, protein 4.2, band 3, and glycophorin B. Loss of the complex reduces red-cell deformability and shortens erythrocyte survival. (andolfo2018hereditarystomatocytosisan pages 9-12, iolascon2019advancesinunderstanding pages 1-2) Strong for membrane-complex biology from reviews and experimental systems GO:0005886 plasma membrane; GO:0016021 integral component of membrane; GO:0008092 cytoskeletal protein binding; GO:0006814 sodium ion transport; GO:0015696 ammonium transport
Protein / transport function RHAG functions as an ammonium and/or CO2 channel in erythrocytes; altered RhAG or absent Rh complex disrupts membrane transport and hydration homeostasis, contributing to stomatocytic morphology and hemolysis. (andolfo2018hereditarystomatocytosisan pages 9-12) Moderate: supported by yeast/oocyte functional studies summarized in review literature GO:0015696 ammonium transport; GO:0015701 bicarbonate transport; CHEBI:28938 ammonium; CHEBI:16526 carbon dioxide
Primary anatomy The principal affected structure is the erythrocyte plasma membrane / red-cell membrane skeleton rather than a parenchymal organ. (narla2017redcellmembrane pages 4-5, iolascon2019advancesinunderstanding pages 1-2) Strong for anatomic localization from red-cell membrane reviews CL:0000232 erythrocyte; UBERON:0000178 blood; GO:0005886 plasma membrane; GO:0005925 focal adhesion/membrane-cytoskeleton interface (approximate)
Cellular players Main cell type affected is the mature erythrocyte; reticulocytes are involved as a laboratory correlate of compensatory erythropoiesis. (hodgkins2020intrinsicdefectsleading pages 19-20, iolascon2019advancesinunderstanding pages 1-2) Strong for erythrocyte involvement; moderate for reticulocyte emphasis CL:0000232 erythrocyte; CL:0000558 reticulocyte
Clinical phenotype: hemolytic anemia Typical presentation is chronic congenital hemolytic anemia due to shortened RBC survival. (narla2017redcellmembrane pages 4-5, iolascon2019advancesinunderstanding pages 1-2) Moderate to strong: consistent across membrane-disorder reviews; disease-specific frequency unavailable HP:0001878 Hemolytic anemia; HP:0001890 Chronic hemolytic anemia
Clinical phenotype: stomatocytosis Stomatocytes on peripheral smear are a classic morphological clue in Rh deficiency / RhAG-related membrane disease. (andolfo2018hereditarystomatocytosisan pages 9-12, narla2017redcellmembrane pages 4-5) Moderate: morphology well established, but percentage varies and disease-specific frequency unavailable HP:0004446 Stomatocytosis
Clinical phenotype: reticulocytosis Reticulocytosis is expected as a compensatory response to chronic hemolysis. (hodgkins2020intrinsicdefectsleading pages 19-20, andolfo2018hereditarystomatocytosisan pages 12-14) Moderate: inferred from hemolysis workup and stomatocytosis review HP:0001923 Reticulocytosis
Clinical phenotype: macrocytosis Macrocytosis / elevated MCV is commonly reported in overhydrated stomatocytic phenotypes related to Rh membrane dysfunction and may be part of Rh-deficiency presentations. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5) Moderate: stronger for RHAG/OHS-related membrane disease than for all Rh-null cases HP:0005518 Increased mean corpuscular volume; HP:0001407 Macrocytosis
Clinical phenotype: jaundice / hyperbilirubinemia Chronic hemolysis can produce jaundice and hyperbilirubinemia, including neonatal presentations in severe congenital hemolytic states. (hodgkins2020intrinsicdefectsleading pages 19-20, andolfo2018hereditarystomatocytosisan pages 12-14) Moderate: broad hereditary hemolysis evidence; disease-specific rates unavailable HP:0000952 Jaundice; HP:0002904 Increased total bilirubin
Clinical phenotype: splenomegaly Splenomegaly is reported in many chronic hemolytic anemias and may occur in Rh deficiency syndrome as part of extravascular hemolysis. (narla2017redcellmembrane pages 4-5) Limited to moderate: extrapolated from hereditary membrane hemolysis literature; disease-specific primary frequency unavailable HP:0001744 Splenomegaly; UBERON:0002106 spleen
Clinical phenotype: gallstones Pigment gallstones/cholelithiasis are recognized complications of chronic hemolysis and may occur in Rh deficiency syndrome. (narla2017redcellmembrane pages 4-5) Limited to moderate: complication known for congenital hemolytic anemia; disease-specific frequency unavailable HP:0001081 Cholelithiasis; UBERON:0002110 gallbladder
Clinical phenotype: iron overload Secondary iron overload/hemosiderosis can develop in chronic hemolytic anemias even with limited transfusion exposure. (andolfo2018hereditarystomatocytosisan pages 12-14) Moderate for hereditary stomatocytosis/hemolytic anemia literature; Rh-deficiency-specific prevalence unavailable HP:0003281 Hemosiderosis; HP:0003236 Increased serum ferritin
Disease course / onset Usually congenital or recognized from childhood, with a chronic lifelong course of variable severity. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5) Moderate: natural-history pattern consistent, but large longitudinal cohorts absent HP:0003577 Congenital onset; HP:0011463 Childhood onset
Serology / laboratory identity Diagnostic hallmark is Rh-null or Rhmod serology with absent or markedly reduced Rh antigen expression on red cells; standard hemolysis workup often shows anemia, increased reticulocytes, hyperbilirubinemia, low haptoglobin, and elevated LDH. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE, hodgkins2020intrinsicdefectsleading pages 19-20) Strong for serologic identity; moderate for ancillary labs in disease-specific cases LOINC/SNOMED concept suggestion: Rh blood group typing; HP:0001972 Decreased haptoglobin level; HP:0003151 Increased LDH level
Peripheral blood morphology Peripheral smear may show stomatocytes and other hemolysis-related red-cell shape abnormalities; anemia is commonly macrocytic in overhydrated states. (andolfo2018hereditarystomatocytosisan pages 9-12, narla2017redcellmembrane pages 4-5) Moderate HP:0004446 Stomatocytosis; HP:0001877 Abnormal erythrocyte morphology
Functional membrane testing Osmotic gradient ektacytometry is considered the best diagnostic technique for red-cell membrane transport disorders, though availability is limited. Indirect tests include osmotic fragility/Pink test/AGLT where relevant. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5) Moderate to strong for membrane-disorder diagnosis; disease-specific use supported by overlap with stomatocytic phenotypes NCIT: C120675 Osmotic Fragility Test (approximate); diagnostic procedure concept: ektacytometry
Genetic testing Recommended molecular approach is targeted NGS / red-cell membrane disorder panel including RHAG, and if Rh-null serology is present, evaluation of RHD/RHCE. Broader exome/genome testing may be useful in unresolved cases. (andolfo2018hereditarystomatocytosisan pages 12-14, OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE) Moderate: review-based recommendation; no disease-specific trial data NCIT: C84351 Genetic Testing; HGNC:9881 RHAG; HGNC:10009 RHD; HGNC:10008 RHCE
Differential diagnosis Key differentials include other hereditary stomatocytoses, hereditary spherocytosis, dehydrated hereditary stomatocytosis/xerocytosis, and other congenital hemolytic anemias. (narla2017redcellmembrane pages 4-5, iolascon2019advancesinunderstanding pages 1-2) Strong for class-level differential diagnosis MONDO suggestions: hereditary stomatocytosis; hereditary spherocytosis
Treatment: supportive care Management is largely supportive: folate/B12 supplementation when indicated, transfusion for severe anemia/aplastic crises, neonatal phototherapy if hyperbilirubinemic, and iron chelation if overload develops. (andolfo2018hereditarystomatocytosisan pages 12-14) Moderate: based on hereditary stomatocytosis/hemolytic anemia management reviews; no Rh-deficiency-specific controlled trials NCIT: C156818 Supportive Care; NCIT: C25179 Blood Transfusion; NCIT: C15313 Phototherapy; NCIT: C15784 Iron Chelation Therapy
Treatment: splenectomy caution Splenectomy should generally be avoided/used with extreme caution in overhydrated/dehydrated hereditary stomatocytic disorders because of ineffectiveness and thromboembolic risk; this principle is commonly extended when Rh-deficiency presents within this membrane-transport phenotype spectrum. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5) Moderate: strong for HSt spectrum, indirect for classical Rh-null syndrome NCIT: C17173 Splenectomy; HP:0001907 Thromboembolism
Transfusion medicine Patients have major rare-blood transfusion challenges; if transfusion is required, Rh-null-compatible units or carefully selected rare-donor blood are needed, making advance transfusion planning essential. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE) Moderate: well established in rare-donor literature; few modern case series NCIT: C25179 Blood Transfusion; rare donor registry concept
Prevention / counseling No primary environmental prevention is known; genetic counseling, family studies, carrier testing in affected pedigrees, and rare-donor registry linkage are the main preventive/public-health measures. (andolfo2018hereditarystomatocytosisan pages 12-14, OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE) Moderate NCIT: C15709 Genetic Counseling
Epidemiology Population prevalence, incidence, sex ratio, and carrier frequency are not robustly established because Rh deficiency syndrome is exceptionally rare and reported mainly through single cases/families. Explicit frequency estimates should therefore be marked unavailable rather than inferred. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE) Strong for evidence gap: rarity is clear; quantitative rates unavailable epidemiology field: unavailable/not established
Evidence limitations Much of the literature mixes classical Rh-null syndrome with related RHAG-associated overhydrated stomatocytosis/Rhmod phenotypes; ontology curation should preserve this distinction while linking shared membrane-pathobiology. (andolfo2018hereditarystomatocytosisan pages 9-12, narla2017redcellmembrane pages 4-5) Strong curator note based on cross-source synthesis curation note; MONDO cross-reference candidate

Table: This ontology-ready table summarizes the highest-yield curated facts for Rh deficiency syndrome, including genetics, phenotypes, anatomy, diagnosis, and supportive management. It is designed to support disease knowledge-base curation while explicitly marking where epidemiologic frequencies remain unavailable.

1. Disease information

Definition and identifiers

Preferred name: Rh deficiency syndrome.
MONDO: MONDO:0019107.
Common synonyms: Rh-null syndrome, Rhnull disease, Rh-null phenotype, Rh-deficiency syndrome, Rh antigen deficiency; Rhmod syndrome denotes markedly reduced rather than completely absent Rh-complex expression.

The disease should not be confused with ordinary RhD-negative blood type, in which D antigen is absent but other Rh-system antigens and the membrane complex remain substantially intact. In Rh-null disease, all or nearly all Rh antigens are absent, with consequences for membrane integrity and transfusion compatibility.

Open Targets associates RHAG, RHCE, and RHD with the disease and cites foundational human genetic evidence including PMID 8563755, 9716608, 10467273, 9657766, 9657769, 1503086, and 16271106. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE)

No uniquely specific ICD-10-CM or ICD-11 code was verified. In practice, coding may use categories for hereditary hemolytic anemia or other specified red-cell membrane disorders, supplemented by the molecular/serologic diagnosis. A dedicated MeSH disease heading was likewise not established in the retrieved evidence.

Evidence provenance: the knowledge base is derived chiefly from aggregated disease resources, transfusion-reference literature, and individual patients or families reported in case studies—not from population-scale EHR cohorts.

2. Etiology

Causal factors and genetic risk

Classical Rh deficiency is Mendelian and predominantly autosomal recessive:

  1. Regulator type: biallelic pathogenic variants in RHAG prevent normal assembly or surface expression of the Rh complex, secondarily suppressing RHD/RHCE antigen expression.
  2. Amorph type: nonfunctional RHD/RHCE alleles occur on both inherited Rh haplotypes, producing no functional Rh polypeptides despite the presence of RHAG.
  3. Rhmod: hypomorphic RHAG variants permit low or qualitatively abnormal Rh expression.

Open Targets assigns the strongest disease association to RHAG (ENSG00000112077), followed by RHCE and RHD; this hierarchy is consistent with RHAG’s role as an obligatory organizer of the erythroid Rh complex. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE)

Reported pathogenic classes include nonsense, frameshift, canonical splice-site, missense, and complex haplotypic defects. They are germline; somatic Rh-antigen loss in myeloid disease is a different acquired phenomenon. Most family-specific alleles are too rare for meaningful population-frequency estimates, and a variant absent from gnomAD is not automatically pathogenic without segregation, serology, and functional evidence.

Environmental, infectious, and lifestyle risks

No toxin, infection, diet, occupation, smoking behavior, or other environmental exposure is known to cause Rh deficiency syndrome. Intercurrent infection—particularly parvovirus B19—can nevertheless precipitate an aplastic crisis in a person with chronic congenital hemolysis. Transfusion exposure is clinically important because it can induce antibodies against high-prevalence Rh antigens.

Protective factors and gene–environment interaction

No validated protective allele or environmental protective factor has been established. Practical risk reduction consists of avoiding unnecessary transfusion, extended antigen matching, and advance rare-donor planning. There is no established disease-specific gene–environment interaction comparable to oxidant-triggered G6PD deficiency.

3. Phenotypes

The phenotype is congenital but variable. Quantitative frequencies cannot be assigned reliably because published evidence consists mainly of isolated families and case series.

Phenotype Type and usual course Suggested HPO term
Chronic hemolytic anemia Core laboratory/clinical phenotype; mild to severe, lifelong HP:0001878 Hemolytic anemia; HP:0001890 Chronic hemolytic anemia
Stomatocytosis Red-cell morphological sign; variable fraction of smear HP:0004446 Stomatocytosis
Reticulocytosis Compensatory laboratory abnormality HP:0001923 Reticulocytosis
Macrocytosis/increased MCV Common in overhydrated stomatocytic presentations HP:0005518 Increased mean corpuscular volume
Reduced haptoglobin; increased LDH and unconjugated bilirubin Hemolysis markers HP:0001972 Decreased haptoglobin; HP:0003151 Increased LDH; HP:0002904 Hyperbilirubinemia
Jaundice Episodic or persistent depending on hemolytic burden HP:0000952 Jaundice
Splenomegaly Secondary to chronic erythrocyte clearance; variable HP:0001744 Splenomegaly
Cholelithiasis Late complication of chronic bilirubin turnover HP:0001081 Cholelithiasis
Iron overload/hemosiderosis May reflect transfusion and increased absorption HP:0003281 Hemosiderosis

Hereditary membrane disorders broadly produce “decreased cell deformability and shortened erythrocyte survival,” an exact summary from the 2019 review by Iolascon and colleagues. (iolascon2019advancesinunderstanding pages 1-2) In overhydrated stomatocytosis, increased intracellular cation and water content raises MCV, lowers MCHC, increases osmotic fragility, and produces uncompensated hemolytic anemia with stomatocytes. (narla2017redcellmembrane pages 4-5)

Quality-of-life data specific to Rh deficiency—EQ-5D, SF-36, PROMIS, employment, or functional-disability scores—have not been published in adequate cohorts. Likely burdens include chronic fatigue, jaundice, monitoring for iron overload, transfusion dependence in severe cases, and substantial anxiety caused by difficulty sourcing compatible blood.

4. Genetic and molecular information

Causal genes

  • RHAG—Rh-associated glycoprotein; strongest regulator-type gene-disease association.
  • RHD—RhD antigen polypeptide.
  • RHCE—RhCE antigen polypeptide.

The Rh complex includes RhAG and Rh proteins together with glycophorin B, CD47, ICAM4/LW, band 3, and protein 4.2. It is coupled directly to ankyrin-R and indirectly through CD47–protein 4.2 interactions. (andolfo2018hereditarystomatocytosisan pages 9-12)

Functional consequences

Classical regulator-type variants generally cause loss of function, defective trafficking/assembly, or failure of Rh proteins to reach the membrane. Amorph-type RHD/RHCE alleles eliminate functional Rh polypeptides. By contrast, RHAG variants p.Ile61Arg and p.Phe65Ser described in overhydrated hereditary stomatocytosis widen a cytoplasmic pore constriction and produce increased cation flux—a gain-of-function mechanism and a related but distinct phenotype. (andolfo2018hereditarystomatocytosisan pages 9-12)

No reproducible modifier gene, pathogenic methylation signature, histone abnormality, or recurrent large chromosomal rearrangement is established for classical Rh deficiency. Chromosomal microarray is therefore not a first-line test unless syndromic features suggest a copy-number disorder.

Recent human variant reports

Recent literature has continued to expand the private RHAG allele spectrum rather than identify a common mutation or new pathway:

  • Hellberg et al., 2023, “A novel nonsense variant in RHAG underlies a Nordic Rhnull phenotype,” Vox Sanguinis 118:690–694. DOI: 10.1111/vox.13478.
  • Qing et al., April 2024, “A novel frameshift mutation in RHAG leads to Rhnull phenotype in a Chinese individual,” Transfusion 64:789–792. DOI: 10.1111/trf.17817.
  • Banerjee et al., May 2024, an Indian Rhnull patient with RHAG c.1138+2T>A, Transfusion Medicine 34:223–226. DOI: 10.1111/tme.13045.

These reports support marked allelic heterogeneity and the practical value of sequencing RHAG in serologically confirmed regulator-type cases. The overall curated gene evidence remains strongest for RHAG, RHCE, and RHD. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE)

5. Environmental information

Environmental toxins, radiation, pollution, occupation, diet, alcohol, and tobacco have no established etiologic role. No infectious organism causes the inherited phenotype, and the disease is not transmissible. Infection can worsen anemia nonspecifically; transfusion and pregnancy can expose affected individuals to missing Rh antigens and provoke clinically important alloimmunization.

6. Mechanism and pathophysiology

Causal chain

Upstream: biallelic RHAG loss/hypomorphism, or combined nonfunctional RHD/RHCE haplotypes
→ absent or markedly reduced erythrocyte Rh complex
→ impaired membrane-protein assembly, membrane-skeleton anchoring, and gas/cation transport
→ abnormal cation-water homeostasis and decreased membrane mechanical stability
→ stomatocytic morphology, reduced deformability, and splenic clearance
→ chronic hemolytic anemia, reticulocytosis, unconjugated hyperbilirubinemia, jaundice and splenomegaly
→ downstream gallstones, iron loading, and occasional transfusion dependence.

RHAG has experimental activity as an ammonium and/or CO₂ channel. Evidence includes complementation of ammonium-transporter-deficient yeast and methyl-ammonium uptake in Xenopus laevis oocytes expressing RHAG. (andolfo2018hereditarystomatocytosisan pages 9-12) Red-cell volume is highly dependent on cation homeostasis; excess intracellular cation increases water and cell volume, reducing excess surface area relative to volume and thereby reducing deformability. (narla2017redcellmembrane pages 4-5)

Cells, tissues, and suggested ontology terms

  • Primary cell: mature erythrocyte—CL:0000232.
  • Compensatory cell: reticulocyte—CL:0000558.
  • Primary process: erythrocyte homeostasis; membrane organization; cytoskeleton organization; ion transport; ammonium transport; erythrocyte clearance.
  • Suggested GO: GO:0005886 plasma membrane; GO:0016021 integral component of membrane; GO:0007010 cytoskeleton organization; GO:0015696 ammonium transport; GO:0006811 ion transport.
  • Chemicals: ammonium—CHEBI:28938; carbon dioxide—CHEBI:16526.

There is no evidence that autoimmunity or primary inflammation drives the disease. Immune involvement is secondary, principally alloantibody formation after exposure to nonself Rh antigens.

Molecular profiling and advanced technologies

No validated disease-specific transcriptomic, single-cell, spatial-transcriptomic, metabolomic, lipidomic, or epigenomic signature is available. Proteomic studies of the normal and deficient erythrocyte membrane have clarified Rh-complex composition, but these are not clinical biomarkers. Targeted NGS is the principal modern omics application. Broader inherited-anemia panels have reported diagnostic yields above 80% in selected cohorts and approximately 73% in one center’s experience, although these figures are not specific to Rh deficiency. (andolfo2018hereditarystomatocytosisan pages 12-14)

7. Anatomical structures affected

The primary lesion is cellular rather than organ-based:

  • Erythrocyte plasma membrane and membrane skeleton—GO:0005886; blood, UBERON:0000178.
  • Spleen, UBERON:0002106—secondary erythrocyte sequestration and possible splenomegaly.
  • Liver/biliary system—secondary bilirubin handling, jaundice, iron deposition, and pigment gallstones.
  • Bone marrow—compensatory erythroid hyperplasia may occur but is not the primary lesion.

Lateralization is not applicable. The membrane cytoskeleton is a spectrin–ankyrin–protein 4.1R–actin network linked to transmembrane complexes; disruption reduces membrane stability and erythrocyte lifespan. (iolascon2019advancesinunderstanding pages 1-2)

8. Temporal development

The molecular defect is congenital and lifelong. Recognition may occur neonatally, in childhood after investigation of jaundice or anemia, or later following blood typing, pregnancy, or transfusion difficulty. Severity is variable rather than predictably progressive. Hemolysis is usually chronic, with episodic worsening during physiological stress or infection. Secondary iron loading and pigment gallstones are cumulative complications. No formal disease stages, remission criteria, or validated longitudinal progression model exist.

9. Inheritance and population

Both sexes are affected because inheritance is autosomal. Classical regulator-type and amorph-type Rh-null disease are usually autosomal recessive; parental consanguinity can increase risk, but many reported patients are compound heterozygotes without known consanguinity. Penetrance of complete biallelic loss appears high for the serologic phenotype, while clinical expressivity varies.

No anticipation, recurrent germline mosaicism, or validated sex bias has been demonstrated. Founder effects may exist for individual rare alleles, but no globally important founder variant or defensible carrier frequency has been established.

Epidemiology: reliable prevalence, incidence, age distribution, sex ratio, and geographic rates are unavailable. Published evidence is dominated by individual families across multiple ancestries. It is safer for a knowledge base to record “exceptionally rare; quantitative prevalence not established” than to reproduce informal media estimates.

10. Diagnostics

Recommended workflow

  1. Confirm hemolysis: CBC, reticulocyte count, unconjugated bilirubin, LDH, haptoglobin, and direct antiglobulin test.
  2. Review smear: look for stomatocytes and other abnormal erythrocyte forms.
  3. Specialist immunohematology: test D, C, c, E, e and high-prevalence Rh antigens; use adsorption/elution or molecular blood-group methods where required. Complete absence supports Rh-null; markedly reduced expression supports Rhmod.
  4. Membrane physiology: osmotic gradient ektacytometry. In overhydrated states, a right-shifted minimum deformability point is expected; test availability is limited. Osmotic fragility, Pink test, or acidified glycerol lysis testing may provide indirect support but are not specific. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5)
  5. Molecular confirmation: sequence and deletion/duplication analysis of RHAG, RHD, and RHCE, interpreted with parental segregation and serology. A red-cell membrane/hemolytic-anemia panel is useful when the phenotype is not specific. WES or WGS is reasonable after nondiagnostic panel testing.

CMA, karyotyping, FISH, mitochondrial sequencing, and repeat-expansion testing are not routine tests for isolated Rh deficiency.

Differential diagnosis

Differentiate from ordinary RhD negativity, autoimmune hemolytic anemia, hereditary spherocytosis, PIEZO1- or KCNN4-related dehydrated hereditary stomatocytosis, RHAG gain-of-function overhydrated stomatocytosis, SLC4A1-related membrane disease, red-cell enzyme deficiencies, unstable hemoglobin, and congenital dyserythropoietic anemia. Ektacytometry plus molecular testing is useful because smear morphology alone is not sufficiently specific. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5)

Screening

Rh deficiency is not part of standard newborn screening. Appropriate approaches are cascade serology/genotyping in relatives, carrier testing in a molecularly defined family, and prenatal or preimplantation testing when familial pathogenic variants are known. Population-wide carrier screening is not supported by prevalence or cost-effectiveness evidence.

11. Outcomes and prognosis

No 5- or 10-year survival estimates, disease-specific mortality rates, or validated prognostic biomarkers exist. Many affected people survive into adulthood, but outcome depends on hemolytic severity, iron loading, gallstone disease, aplastic crises, pregnancy-related alloimmunization, and access to compatible blood.

Important morbidity includes fatigue and anemia, jaundice, splenomegaly, pigment gallstones, iron overload, and transfusion complications. Ferritin, transferrin saturation, liver iron concentration, and T2* MRI are used to monitor iron loading in hereditary stomatocytic anemias. (andolfo2018hereditarystomatocytosisan pages 12-14)

12. Treatment

There is no approved therapy that restores the Rh complex.

  • Observation and hematology follow-up for compensated disease.
  • Folic acid when erythropoietic demand is increased; vitamin B12 only if deficient or clinically indicated.
  • Red-cell transfusion for severe symptomatic anemia or aplastic crisis. Compatibility planning is unusually difficult: Rh-null recipients may form antibodies to high-prevalence Rh antigens and may require frozen autologous units, family donors, or international rare-donor registries.
  • Neonatal phototherapy or exchange transfusion according to bilirubin thresholds, with rare-compatible blood planning.
  • Iron surveillance and chelation—deferoxamine, deferasirox, or deferiprone—when clinically significant iron overload is established. (andolfo2018hereditarystomatocytosisan pages 12-14)
  • Gallbladder management according to standard indications for symptomatic cholelithiasis.

Suggested NCIT annotations include Blood Transfusion, Supportive Care, Phototherapy, Iron Chelation Therapy, Genetic Counseling, and Splenectomy.

Splenectomy requires caution. In hereditary stomatocytosis, expert reviews report that it may be ineffective or only partially effective and can substantially increase thromboembolic risk; it is contraindicated in dehydrated and overhydrated hereditary stomatocytosis. This evidence should not be overgeneralized automatically to every classical Rh-null patient, but surgery should only follow expert membrane-disorder evaluation. (andolfo2018hereditarystomatocytosisan pages 12-14, narla2017redcellmembrane pages 4-5)

No disease-specific gene therapy, RNA therapy, cell therapy, targeted drug, or immunotherapy is in established clinical use, and the ClinicalTrials.gov search found no relevant interventional trial.

13. Prevention

Primary prevention by lifestyle or vaccination is not possible. Prevention is genetic and transfusion-focused:

  • genetic counseling and autosomal-recessive recurrence-risk assessment;
  • cascade testing and reproductive options when familial variants are known;
  • comprehensive antibody history and extended molecular blood-group typing;
  • enrollment in rare-donor registries;
  • avoidance of unnecessary transfusion and use of maximally compatible units;
  • consideration of autologous blood cryopreservation when feasible;
  • prospective multidisciplinary planning before surgery or pregnancy;
  • surveillance for bilirubin complications and iron overload.

A 2023 report illustrates the obstetric risk of severe fetal anemia from red-cell alloimmunization in an Rh-null woman: Cuvellier et al., Transfusion Medicine 33:420–422, DOI 10.1111/tme.12990. This is a transfusion/pregnancy complication, not an environmental cause of the syndrome.

14. Other species and natural disease

No well-established naturally occurring veterinary equivalent was identified in the retrieved literature, and there is no zoonotic potential. RH/RHAG orthologues are evolutionarily conserved across vertebrates, but animal blood-group systems and erythrocyte physiology differ enough that orthology alone does not establish a natural Rh-null syndrome. Taxonomic and breed-specific prevalence data are unavailable.

15. Model organisms and experimental systems

  • Yeast: ammonium-transporter-deficient Saccharomyces cerevisiae has been used for RHAG complementation, supporting ammonium transport.
  • Xenopus oocytes: expression of human RHAG permits methyl-ammonium/cation-flux assays; overhydrated-stomatocytosis variants produce larger fluxes than wild type. (andolfo2018hereditarystomatocytosisan pages 9-12)
  • Mouse: Rh/Rhag-deficient genetic models are useful for membrane-complex assembly, red-cell morphology, osmotic fragility, and survival. Their limitations include species-specific Rh architecture and incomplete reproduction of human alloimmunization and transfusion constraints.
  • Human erythroid cells: patient RBCs and ex-vivo erythroid cultures remain the most directly relevant systems. Mature RBCs are enucleated, limiting conventional transcriptomics and CRISPR interrogation at the final cell stage.

Evidence quality and curation cautions

  1. Human evidence predominates but is sparse: most disease-specific observations are case reports, pedigrees, and transfusion studies rather than cohorts.
  2. Mechanistic evidence is mixed: membrane composition and clinical hemolysis are human observations; channel activity relies partly on yeast, oocyte, and modeling experiments. (andolfo2018hereditarystomatocytosisan pages 9-12)
  3. Do not merge distinct RHAG disorders: biallelic loss causing regulator-type Rh-null/Rhmod disease differs from heterozygous gain-of-function RHAG-associated overhydrated stomatocytosis.
  4. Do not assign unsupported frequencies: phenotype percentages, incidence, life expectancy, sex ratio, and population carrier rates are not presently robust.
  5. Recent research direction: 2023–2024 work mainly adds private RHAG variants and improves rare-blood molecular diagnostics and pregnancy/transfusion management; it has not yet produced disease-modifying therapy.

Selected authoritative references

  • Andolfo I, Russo R, Gambale A, Iolascon A. “Hereditary stomatocytosis: An underdiagnosed condition.” American Journal of Hematology. Published January 2018;93:107–121. DOI: 10.1002/ajh.24929. The review details RHAG channel biology, diagnosis, NGS, and management. (andolfo2018hereditarystomatocytosisan pages 9-12, andolfo2018hereditarystomatocytosisan pages 12-14)
  • Iolascon A, Andolfo I, Russo R. “Advances in understanding the pathogenesis of red cell membrane disorders.” British Journal of Haematology. Published 2019;187:13–24. DOI: 10.1111/bjh.16126. Its abstract states: “Hereditary erythrocyte membrane disorders are caused by mutations in genes encoding various transmembrane or cytoskeletal proteins of red blood cells.” (iolascon2019advancesinunderstanding pages 1-2)
  • Narla J, Mohandas N. “Red cell membrane disorders.” International Journal of Laboratory Hematology. Published April 2017;39(S1):47–52. DOI: 10.1111/ijlh.12657. (narla2017redcellmembrane pages 4-5)
  • Cartron J-P. “Rh blood group system and molecular basis of Rh-deficiency.” Best Practice & Research Clinical Haematology. Published December 1999;12:655–689. DOI: 10.1053/beha.1999.0047.
  • Avent ND, Reid ME. “The Rh blood group system: a review.” Blood. Published January 2000;95:375–387. DOI: 10.1182/blood.V95.2.375.

Overall, Rh deficiency syndrome is best represented as a congenital, primarily erythrocyte-membrane disease with strong RHAG/RHD/RHCE genetic evidence, a clinically variable hemolytic phenotype, and an unusually consequential rare-blood transfusion problem. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE, andolfo2018hereditarystomatocytosisan pages 9-12, iolascon2019advancesinunderstanding pages 1-2)

References

  1. (OpenTargets Search: Rh deficiency syndrome-RHAG,RHD,RHCE): Open Targets Query (Rh deficiency syndrome-RHAG,RHD,RHCE, 10 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  2. (andolfo2018hereditarystomatocytosisan pages 9-12): Immacolata Andolfo, Roberta Russo, Antonella Gambale, and Achille Iolascon. Hereditary stomatocytosis: an underdiagnosed condition. American Journal of Hematology, 93:107-121, Jan 2018. URL: https://doi.org/10.1002/ajh.24929, doi:10.1002/ajh.24929. This article has 101 citations and is from a domain leading peer-reviewed journal.

  3. (narla2017redcellmembrane pages 4-5): J. Narla and N. Mohandas. Red cell membrane disorders. International Journal of Laboratory Hematology, 39:47-52, Apr 2017. URL: https://doi.org/10.1111/ijlh.12657, doi:10.1111/ijlh.12657. This article has 228 citations and is from a peer-reviewed journal.

  4. (iolascon2019advancesinunderstanding pages 1-2): Achille Iolascon, Immacolata Andolfo, and Roberta Russo. Advances in understanding the pathogenesis of red cell membrane disorders. British Journal of Haematology, 187:13-24, Jul 2019. URL: https://doi.org/10.1111/bjh.16126, doi:10.1111/bjh.16126. This article has 126 citations and is from a domain leading peer-reviewed journal.

  5. (hodgkins2020intrinsicdefectsleading pages 19-20): S. Renee Hodgkins. Intrinsic defects leading to increased erythrocyte destruction. ArXiv, pages 336-362, Jan 2024. URL: https://doi.org/10.1016/b978-0-323-53045-3.00030-1, doi:10.1016/b978-0-323-53045-3.00030-1. This article has 5 citations.

  6. (andolfo2018hereditarystomatocytosisan pages 12-14): Immacolata Andolfo, Roberta Russo, Antonella Gambale, and Achille Iolascon. Hereditary stomatocytosis: an underdiagnosed condition. American Journal of Hematology, 93:107-121, Jan 2018. URL: https://doi.org/10.1002/ajh.24929, doi:10.1002/ajh.24929. This article has 101 citations and is from a domain leading peer-reviewed journal.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 10
Resolved 10
Unresolved (possible confabulation) 0
Unverifiable 0

All extracted references resolved successfully.